Medpace(MEDP)

Search documents
Medpace(MEDP) - 2021 Q3 - Quarterly Report
2021-10-26 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 5375 Medpace Way, Cincinnati, OH 45227 (Address of principal executive offices) (Zip Code) (513) 579-9911 (Registra ...
Medpace(MEDP) - 2021 Q3 - Earnings Call Transcript
2021-10-26 16:45
Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2021 Earnings Conference Call October 26, 2021 9:00 AM ET Company Participants Lauren Morris - Director of Investor Relations August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO Conference Call Participants John Kreger - William Blair Donald Hooker - KeyBanc Dave Windley - Jefferies Operator Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter 2021 Earnings Conference Call [Operator Instructions]. As a reminder, this call may be record ...
Medpace(MEDP) - 2021 Q2 - Quarterly Report
2021-07-27 20:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other jurisd ...
Medpace(MEDP) - 2021 Q2 - Earnings Call Transcript
2021-07-27 14:34
Medpace Holdings, Inc. (NASDAQ:MEDP) Q2 2021 Earnings Conference Call July 27, 2021 9:00 AM ET Company Participants Lauren Morris - Associate Director of IR August Troendle - President and CEO Jesse Geiger - CFO and COO, Laboratory Operations Kevin Brady - Executive Director of Finance Conference Call Participants Justin Lin - William Blair Dave Windley - Jefferies Operator Good day, ladies and gentlemen, and welcome to the Medpace Second Quarter 2021 Earnings Conference Call. At this time, all participants ...
Medpace(MEDP) - 2021 Q1 - Quarterly Report
2021-04-27 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission file number: 001-37856 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other juris ...
Medpace(MEDP) - 2021 Q1 - Earnings Call Transcript
2021-04-27 16:15
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2021 Earnings Conference Call April 27, 2021 9:00 AM ET Company Participants Kevin Brady - Executive Director of Finance August Troendle - President and CEO Jesse Geiger - CFO and COO of Laboratory Operations Conference Call Participants Sandy Draper - Truist Securities John Kreger - William Blair Dave Windley - Jefferies Erin Wright - Credit Suisse Donald Hooker - KeyBanc Operator Good day, ladies and gentlemen, and welcome to the Medpace First Quarter 2021 Earnings ...
Medpace(MEDP) - 2021 Q1 - Earnings Call Presentation
2021-04-27 12:38
| --- | --- | --- | |-------|-------|-------| | | | | | | | | | | | | FO RWARD LO O KI NG STATEM ENTS & NO N-G AAP FI NANCI AL M EASURES Forward-LookingStatements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding our forecasted financial ...
Medpace(MEDP) - 2020 Q4 - Annual Report
2021-02-16 21:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-37856 Medpace Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 32-0434904 (State or other jurisdicti ...
Medpace(MEDP) - 2020 Q4 - Earnings Call Transcript
2021-02-16 18:36
Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2020 Earnings Conference Call February 16, 2021 9:00 AM ET Company Participants Kevin Brady - Executive Director of Finance Jesse Geiger - CFO & COO, Laboratory Operations August Troendle - Chairman, President & CEO Conference Call Participants David Windley - Jefferies Donald Hooker - KeyBanc Capital Markets Erin Wright - Cr??dit Suisse Alexander Draper - Truist Securities Operator Good day, ladies and gentlemen, and welcome to the Medpace Fourth Quarter and Full Yea ...
Medpace(MEDP) - 2020 Q3 - Earnings Call Presentation
2020-10-30 12:13
| --- | --- | --- | --- | |-------|-------------------|---------------------------|-------| | | | | | | | | | | | | FINANCIAL RESULTS | Q3 2020 OCTOBER 26, 2020 | | FORWARD LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking s ...